UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 229

Sortiert nach

Adverse events of guselkumab in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system

Expert opinion on drug safety, 2023-10, Vol.22 (10), p.943-955

2023

Link zum Volltext

Verfügbarkeit prüfen

Differences in ocular adverse events associated with phosphodiesterase-5 inhibitors: a real-world pharmacovigilance study

Expert opinion on drug safety, 2024-05, p.1-8

2024

Link zum Volltext

Verfügbarkeit prüfen

A real-world pharmacovigilance analysis of the FDA adverse event reporting system events for polatuzumab vedotin

Expert opinion on drug safety, 2024-05, p.1-9

2024

Link zum Volltext

Verfügbarkeit prüfen

New exploration of signal detection of Regional Risks from the perspective of data mining: a pharmacovigilance analysis based on spontaneous reporting data in Zhenjiang, China

Expert opinion on drug safety, 2023-11, p.1-12

2023

Link zum Volltext

Verfügbarkeit prüfen

Sublingual/Buccal buprenorphine and dental problems: a pharmacovigilance study

Expert opinion on drug safety, 2023-12, Vol.22 (12), p.1283-1287

2023

Link zum Volltext

Verfügbarkeit prüfen

Tyrosine kinase inhibitors-associated interstitial lung disease used in non-small cell lung cancer: a pharmacovigilance analysis based on the FDA adverse event reporting system database

Expert opinion on drug safety, 2023-09, Vol.ahead-of-print (ahead-of-print), p.1-8

2023

Link zum Volltext

Verfügbarkeit prüfen

Gender differences in adverse events related to Osimertinib: a real-world pharmacovigilance analysis of FDA adverse event reporting system

Expert opinion on drug safety, 2024-06, Vol.23 (6), p.763-770

2024

Link zum Volltext

Verfügbarkeit prüfen

Ubrogepant and rimegepant: signal detection using spontaneous reports of adverse events from the Food and Drug Administration Adverse Event Reporting System

Expert opinion on drug safety, 2023-11, Vol.ahead-of-print (ahead-of-print), p.1-8

2023

Link zum Volltext

Verfügbarkeit prüfen

Adverse events associated with brolucizumab: a disproportionality analysis of the FDA adverse event reporting system (FAERS)

Expert opinion on drug safety, 2024-02, p.1-6

2024

Link zum Volltext

Verfügbarkeit prüfen

Safety profile of D-penicillamine: a comprehensive pharmacovigilance analysis by FDA adverse event reporting system

Expert opinion on drug safety, 2021-11, Vol.20 (11), p.1443-1450

2021

Link zum Volltext

Verfügbarkeit prüfen

Ocular adverse events of cenegermin used in neurotrophic keratopathy: an analysis of the FDA adverse event reporting system database

Expert opinion on drug safety, 2024, p.1-7

2024

Link zum Volltext

Verfügbarkeit prüfen

Drug-induced hypoglycemia: a disproportionality analysis of the FAERS database

Expert opinion on drug safety, 2023-11, p.1-7

2023

Link zum Volltext

Verfügbarkeit prüfen

A new paradigm in adverse drug reaction reporting: consolidating the evidence for an intervention to improve reporting

Expert opinion on drug safety, 2022-09, Vol.21 (9), p.1193-1204

2022

Link zum Volltext

Verfügbarkeit prüfen

Local anesthetics systemic toxicity association with exparel (bupivacaine liposome)- a pharmacovigilance evaluation

Expert opinion on drug safety, 2018-06, Vol.17 (6), p.581-587

Aggarwal, Nitish

2018

Link zum Volltext

Verfügbarkeit prüfen

Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation

Expert opinion on drug safety, 2017-05, Vol.16 (5), p.515-522

2017

Link zum Volltext

Verfügbarkeit prüfen

Safety assessment of clomiphene: a real-world pharmacovigilance analysis from the Food and Drug Administration adverse event reporting system

Expert opinion on drug safety, 2024-05, p.1-8

2024

Link zum Volltext

Verfügbarkeit prüfen

Adverse tumor events induced by ranitidine: an analysis based on the FAERS database

Expert opinion on drug safety, 2024-05, p.1-13

2024

Link zum Volltext

Verfügbarkeit prüfen

Post-marketing safety concerns with abrocitinib: a real-world pharmacovigilance analysis of the FDA adverse event reporting system

Expert opinion on drug safety, 2024-05, p.1-8

2024

Link zum Volltext

Verfügbarkeit prüfen

Abrocitinib-associated adverse events: a real-world pharmacovigilance study using the FAERS database

Expert opinion on drug safety, 2024-05, p.1-7

2024

Link zum Volltext

Verfügbarkeit prüfen

A real-world disproportionality analysis of the FDA adverse event reporting system events for ibuprofen

Expert opinion on drug safety, 2024-05, p.1-11

2024

Link zum Volltext

Verfügbarkeit prüfen

Long-term safety of lanthanum carbonate in the real word: a 19-year disproportionality analysis from the FDA Adverse Event Reporting System

Expert opinion on drug safety, 2024-04, p.1-8

2024

Link zum Volltext

Verfügbarkeit prüfen

Adverse drug reactions in elderly: a five-year review of spontaneous reports to the Portuguese pharmacovigilance system

Expert opinion on drug safety, 2021-01, Vol.20 (1), p.109-118

2021

Link zum Volltext

Verfügbarkeit prüfen

Reporting of tumor lysis syndrome with targeted therapy for hepatic cancer in the FDA adverse events reporting system

Expert opinion on drug safety, 2024-01, p.1-7

2024

Link zum Volltext

Verfügbarkeit prüfen

Hematological adverse events associated with anti-MRSA agents: a real-world analysis based on FAERS

Expert opinion on drug safety, 2024-01, p.1-11

2024

Link zum Volltext

Verfügbarkeit prüfen

Prevalence, characteristics, and reporting of adverse drug reactions in an Australian hospital: a retrospective review of hospital admissions due to adverse drug reactions

Expert opinion on drug safety, 2021-10, Vol.20 (10), p.1267-1274

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 229

Suche als RSS-Feed

Aktive Filter

SpracheDänisch

Zeitschrift / SerieExpert Opinion On Drug Safety

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(229)
Mit Volltextzugriff
(6)

Publikationsform

Artikel
(229)

Sprache

Englisch
(229)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Pharmacovigilance
(225)
Life Sciences & Biomedicine
(216)
Pharmacology & Pharmacy
(216)
Science & Technology
(216)
Humans
(164)
Adverse Drug Reaction Reporting Systems
(62)
Female
(57)
Male
(56)
Drug-Related Side Effects And Adverse Reactions - Epidemiology
(49)
Faers
(48)
Databases, Factual
(42)
Adverse Drug Reaction Reporting Systems - Statistics & Numerical Data
(41)
Aged
(40)
Adult
(36)
United States Food And Drug Administration
(36)
Adverse Drug Reactions
(34)
Drug Safety
(34)
Middle Aged
(34)
United States
(33)
Adolescent
(28)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Taylor & Francis Journals Complete
(229)
Taylor & Francis
(229)
MEDLINE
(163)

Neu hinzugefügt

... seit 90 Tagen
(16)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Adverse events of guselkumab in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system

Differences in ocular adverse events associated with phosphodiesterase-5 inhibitors: a real-world pharmacovigilance study

A real-world pharmacovigilance analysis of the FDA adverse event reporting system events for polatuzumab vedotin

New exploration of signal detection of Regional Risks from the perspective of data mining: a pharmacovigilance analysis based on spontaneous reporting data in Zhenjiang, China

Sublingual/Buccal buprenorphine and dental problems: a pharmacovigilance study

Tyrosine kinase inhibitors-associated interstitial lung disease used in non-small cell lung cancer: a pharmacovigilance analysis based on the FDA adverse event reporting system database

Gender differences in adverse events related to Osimertinib: a real-world pharmacovigilance analysis of FDA adverse event reporting system

Ubrogepant and rimegepant: signal detection using spontaneous reports of adverse events from the Food and Drug Administration Adverse Event Reporting System

Adverse events associated with brolucizumab: a disproportionality analysis of the FDA adverse event reporting system (FAERS)

Safety profile of D-penicillamine: a comprehensive pharmacovigilance analysis by FDA adverse event reporting system

Ocular adverse events of cenegermin used in neurotrophic keratopathy: an analysis of the FDA adverse event reporting system database

Drug-induced hypoglycemia: a disproportionality analysis of the FAERS database

A new paradigm in adverse drug reaction reporting: consolidating the evidence for an intervention to improve reporting

Local anesthetics systemic toxicity association with exparel (bupivacaine liposome)- a pharmacovigilance evaluation

Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation

Safety assessment of clomiphene: a real-world pharmacovigilance analysis from the Food and Drug Administration adverse event reporting system

Adverse tumor events induced by ranitidine: an analysis based on the FAERS database

Post-marketing safety concerns with abrocitinib: a real-world pharmacovigilance analysis of the FDA adverse event reporting system

Abrocitinib-associated adverse events: a real-world pharmacovigilance study using the FAERS database

A real-world disproportionality analysis of the FDA adverse event reporting system events for ibuprofen

Long-term safety of lanthanum carbonate in the real word: a 19-year disproportionality analysis from the FDA Adverse Event Reporting System

Adverse drug reactions in elderly: a five-year review of spontaneous reports to the Portuguese pharmacovigilance system

Reporting of tumor lysis syndrome with targeted therapy for hepatic cancer in the FDA adverse events reporting system

Hematological adverse events associated with anti-MRSA agents: a real-world analysis based on FAERS

Prevalence, characteristics, and reporting of adverse drug reactions in an Australian hospital: a retrospective review of hospital admissions due to adverse drug reactions

Aktive Filter

Suchergebnisse filtern